Pages that link to "Q38354926"

The following pages link to Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. (Q38354926):

Displaying 50 items.

• A novel hPirh2 splicing variant without ubiquitin protein ligase activity interacts with p53 and is down-regulated in hepatocellular carcinoma (Q24310839) (← links)
• Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains (Q24315623) (← links)
• The Mdm2 oncoprotein interacts with the cell fate regulator Numb (Q24522545) (← links)
• MDM2 regulates dihydrofolate reductase activity through monoubiquitination (Q24634031) (← links)
• Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma (Q24670483) (← links)
• The role of the ubiquitination-proteasome pathway in breast cancer: use of mouse models for analyzing ubiquitination processes (Q24794970) (← links)
• The RNA Splicing Response to DNA Damage (Q26777046) (← links)
• Misregulation of pre-mRNA alternative splicing in cancer (Q27007114) (← links)
• Mdm2 as a chromatin modifier (Q28073903) (← links)
• Role of MDM2 and MDMX in DNA repair (Q28079939) (← links)
• MDM2 interacts with MDMX through their RING finger domains (Q28142437) (← links)
• MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts (Q28200748) (← links)
• The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter (Q28255693) (← links)
• Activation and activities of the p53 tumour suppressor protein (Q28366563) (← links)
• Identification and characterization of a novel Mdm2 splice variant acutely induced by the chemotherapeutic agents adriamycin and actinomycin D (Q28565709) (← links)
• A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2 (Q28588691) (← links)
• Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma (Q30320982) (← links)
• Therapeutic considerations for Mdm2: not just a one trick pony (Q30380490) (← links)
• Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators (Q30832108) (← links)
• Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression (Q33272380) (← links)
• Mdm2: the ups and downs (Q33594040) (← links)
• Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis (Q33601591) (← links)
• The genetics of transitional cell carcinoma: progress and potential clinical application (Q33723575) (← links)
• The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA. (Q33792857) (← links)
• Regulation of p53 stability (Q33807793) (← links)
• mdm2: a bridge over the two tumour suppressors, p53 and Rb. (Q33807825) (← links)
• Phenotype vs genotype in the evolution of astrocytic brain tumors (Q33834813) (← links)
• Mutation of cell cycle regulators and their impact on superficial bladder cancer (Q33851133) (← links)
• The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis (Q33888765) (← links)
• Soft tissue sarcomas and p53 mutations (Q33898768) (← links)
• What we could do now: molecular pathology of bladder cancer (Q33918737) (← links)
• Individual variation in protein-coding sequences of human genome (Q33928607) (← links)
• The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor (Q34030117) (← links)
• Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression. a review of the evidence. (Q34245527) (← links)
• MDM2 regulates a novel form of incomplete neoplastic transformation of Theileria parva infected lymphocytes (Q34415317) (← links)
• Molecular abnormalities in lung carcinogenesis and their potential clinical implications (Q34447403) (← links)
• Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation (Q34545092) (← links)
• The MDM2 gene amplification database (Q34672224) (← links)
• Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination (Q34688242) (← links)
• Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression (Q34707942) (← links)
• Alternative and aberrant splicing of MDM2 mRNA in human cancer (Q34768629) (← links)
• A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene (Q34770842) (← links)
• ROS and p53 in regulation of UVB-induced HDM2 alternative splicing (Q34807527) (← links)
• Recent advances in the molecular diagnosis of lung cancer (Q34936028) (← links)
• Stimulation of human DNA polymerase epsilon by MDM2 (Q34980494) (← links)
• Study of suboptimum treatment response: lessons from breast cancer (Q35080295) (← links)
• Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways (Q35221809) (← links)
• Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage (Q35562067) (← links)
• Mdm2: A regulator of cell growth and death (Q35572466) (← links)
• Human MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops (Q35641639) (← links)